Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth to Use Genedata’s Software for Microarray Analysis

NEW YORK, (GenomeWeb News) - Genedata, an informatics company based in Basel, Switzerland, said today that Wyeth Pharmaceuticals has licensed its software to support its drug discovery efforts.
Genedata said it has integrated its Expressionist and Phylosopher software platforms with Wyeth’s informatics infrastructure to create new analysis portals, allowing researchers to “navigate large result repositories” and to “drill down” for information on data quality and experimental design.
Genedata said its solution offers a platform capable of analyzing “tens of thousands of microarrays per month.”
The company added that Wyeth’s “scientific business rules” have been integrated with Genedata’s analysis workflows.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.